These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34604901)

  • 1. Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis.
    Imperial MZ; Nedelman JR; Conradie F; Savic RM
    Clin Infect Dis; 2022 May; 74(10):1736-1747. PubMed ID: 34604901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.
    Swaminathan A; du Cros P; Seddon JA; Mirgayosieva S; Asladdin R; Dusmatova Z
    BMC Infect Dis; 2017 Jun; 17(1):417. PubMed ID: 28606115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid interruption in patients with fluoroquinolone-resistant tuberculosis receiving a bedaquiline-based treatment regimen.
    Olayanju O; Esmail A; Limberis J; Gina P; Dheda K
    Int J Infect Dis; 2019 Aug; 85():74-79. PubMed ID: 31100421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linezolid: a Promising Agent for the Treatment of Multiple and Extensively Drug-Resistant Tuberculosis.
    Fermeli DD; Marantos TD; Liarakos AD; Panayiotakopoulos GD; Dedes VK; Panoutsopoulos GI
    Folia Med (Plovdiv); 2020 Sep; 62(3):444-452. PubMed ID: 33009738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Severe and Long-lasting Linezolid-induced Optic Neuropathy Reversible?
    Lee S; Kang BH; Ryu WY; Um SJ; Roh MS; Son C
    Intern Med; 2018 Dec; 57(24):3611-3613. PubMed ID: 30101940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
    Alffenaar JW; van Altena R; Harmelink IM; Filguera P; Molenaar E; Wessels AM; van Soolingen D; Kosterink JG; Uges DR; van der Werf TS
    Clin Pharmacokinet; 2010 Aug; 49(8):559-65. PubMed ID: 20608757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis.
    Conradie F; Diacon AH; Ngubane N; Howell P; Everitt D; Crook AM; Mendel CM; Egizi E; Moreira J; Timm J; McHugh TD; Wills GH; Bateson A; Hunt R; Van Niekerk C; Li M; Olugbosi M; Spigelman M;
    N Engl J Med; 2020 Mar; 382(10):893-902. PubMed ID: 32130813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
    J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.
    Garcia-Prats AJ; Schaaf HS; Draper HR; Garcia-Cremades M; Winckler J; Wiesner L; Hesseling AC; Savic RM
    PLoS Med; 2019 Apr; 16(4):e1002789. PubMed ID: 31039153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis.
    Agyeman AA; Ofori-Asenso R
    Ann Clin Microbiol Antimicrob; 2016 Jun; 15(1):41. PubMed ID: 27334498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid Induced Reversible Peripheral Neuropathy.
    Vishnu VY; Modi M; Goyal MK; Lal V
    Am J Ther; 2016; 23(6):e1839-e1841. PubMed ID: 26741956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.
    Jaspard M; Butel N; El Helali N; Marigot-Outtandy D; Guillot H; Peytavin G; Veziris N; Bodaghi B; Flandre P; Petitjean G; Caumes E; Pourcher V
    Emerg Infect Dis; 2020 Aug; 26(8):1792-1800. PubMed ID: 32687026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simple strategy to assess linezolid exposure in patients with multi-drug-resistant and extensively-drug-resistant tuberculosis.
    Kamp J; Bolhuis MS; Tiberi S; Akkerman OW; Centis R; de Lange WC; Kosterink JG; van der Werf TS; Migliori GB; Alffenaar JC
    Int J Antimicrob Agents; 2017 Jun; 49(6):688-694. PubMed ID: 28389352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B; Sandven P; Brubakk O
    J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of longer linezolid regimen in children with drug-resistant tuberculosis and extensive tuberculosis in Southwest China.
    Zhang Z; Cheng Z; Liu Q; Shang T; Jiang L; Fu Z; Zhu K; Wang X; Chen J; Xu H
    J Glob Antimicrob Resist; 2020 Jun; 21():375-379. PubMed ID: 31593796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum.
    Saroha D; Garg D; Singh AK; Dhamija RK
    Indian J Tuberc; 2020 Jul; 67(3):389-392. PubMed ID: 32825876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid in the treatment of multidrug-resistant tuberculosis.
    Schecter GF; Scott C; True L; Raftery A; Flood J; Mase S
    Clin Infect Dis; 2010 Jan; 50(1):49-55. PubMed ID: 19947856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited sampling strategies for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis.
    Alffenaar JW; Kosterink JG; van Altena R; van der Werf TS; Uges DR; Proost JH
    Ther Drug Monit; 2010 Feb; 32(1):97-101. PubMed ID: 20042919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.